Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Receives Average Recommendation of “Buy” from Analysts

Posted by Editorial Team on May 11th, 2025

Shares of Reckitt Benckiser Group plc (OTCMKTS:RBGLY – Get Free Report) have received a consensus recommendation of “Buy” from the eight ratings firms that are currently covering the company, MarketBeat.com reports. Three analysts have rated the stock with a hold rating, two have assigned a buy rating and three have issued a strong buy rating on the company.

Several research firms recently issued reports on RBGLY. Barclays downgraded Reckitt Benckiser Group from an “overweight” rating to an “equal weight” rating in a research note on Tuesday, February 4th. Royal Bank of Canada reissued an “outperform” rating on shares of Reckitt Benckiser Group in a research report on Friday, March 7th.

Check Out Our Latest Analysis on Reckitt Benckiser Group

Reckitt Benckiser Group Trading Down 0.1 %

Shares of OTCMKTS:RBGLY opened at $13.03 on Tuesday. The company has a debt-to-equity ratio of 0.97, a quick ratio of 0.47 and a current ratio of 0.69. Reckitt Benckiser Group has a 12-month low of $10.43 and a 12-month high of $14.10. The business has a 50 day moving average of $13.15 and a 200-day moving average of $12.74.

Reckitt Benckiser Group Increases Dividend

The firm also recently announced a dividend, which will be paid on Thursday, June 5th. Shareholders of record on Friday, April 11th will be issued a dividend of $0.2909 per share. This is a positive change from Reckitt Benckiser Group’s previous dividend of $0.19. The ex-dividend date of this dividend is Friday, April 11th.

About Reckitt Benckiser Group

(Get Free Report

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.